Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review
Simple Summary Breast cancer is the most common cancer among women. It is estimated
that 2.3 million new cases of BC are diagnosed globally each year. Based on mRNA gene …
that 2.3 million new cases of BC are diagnosed globally each year. Based on mRNA gene …
The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis
Introduction Cancer remains a leading cause of death worldwide. While a curative intent is
the aim of any surgical treatment many patients either present with or go onto develop …
the aim of any surgical treatment many patients either present with or go onto develop …
Prognostic utility of platelet–lymphocyte ratio, neutrophil–lymphocyte ratio and monocyte–lymphocyte ratio in head and neck cancers: a detailed PRISMA compliant …
Simple Summary Inflammation plays a major role in cancer development and progression
and has the potential to be used as a prognostic marker in cancer. Previous studies have …
and has the potential to be used as a prognostic marker in cancer. Previous studies have …
The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
MH Kang, SI Go, HN Song, A Lee, SH Kim… - British journal of …, 2014 - nature.com
Background: The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio
(PLR) are prognostic factors for various types of cancer. In this study, we assessed the …
(PLR) are prognostic factors for various types of cancer. In this study, we assessed the …
Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis
TF Nishijima, HB Muss, SS Shachar, K Tamura… - Cancer treatment …, 2015 - Elsevier
Background The immune system plays an important role in cancer pathogenesis. A low
lymphocyte-to-monocyte ratio (LMR), as a simple biomarker of host immune system, has …
lymphocyte-to-monocyte ratio (LMR), as a simple biomarker of host immune system, has …
Comparisons of neutrophil‐, monocyte‐, eosinophil‐, and basophil‐lymphocyte ratios among various systemic autoimmune rheumatic diseases
Z Yang, Z Zhang, F Lin, Y Ren, D Liu, R Zhong… - Apmis, 2017 - Wiley Online Library
This study was aimed to evaluate levels of neutrophil‐(NLR), monocyte‐(MLR), eosinophil‐
(ELR), and basophil‐lymphocyte ratio (BLR) and their association with inflammatory markers …
(ELR), and basophil‐lymphocyte ratio (BLR) and their association with inflammatory markers …
Neutrophil‐to‐lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma
Background Current prognostic criteria are insufficient in predicting outcomes in head and
neck cancer, necessitating new, readily available biomarkers. Methods Pretreatment …
neck cancer, necessitating new, readily available biomarkers. Methods Pretreatment …
[HTML][HTML] Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis
L Gu, H Li, L Chen, X Ma, X Li, Y Gao, Y Zhang, Y **e… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Inflammation influences cancer development and progression, and a low lymphocyte to
monocyte ratio (LMR) has been reported to be a poor prognostic indicator in several …
monocyte ratio (LMR) has been reported to be a poor prognostic indicator in several …
Prognostic significance of systemic inflammation-based lymphocyte-monocyte ratio in patients with lung cancer: based on a large cohort study
P Hu, H Shen, G Wang, P Zhang, Q Liu, J Du - PloS one, 2014 - journals.plos.org
Increasing evidence indicates cancer-related inflammatory biomarkers show great promise
for predicting the outcome of cancer patients. The lymphocyte-monocyte ratio (LMR) was …
for predicting the outcome of cancer patients. The lymphocyte-monocyte ratio (LMR) was …
The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis
In this review, we discuss the interaction between cancer and markers of inflammation (such
as levels of inflammatory cells and proteins) in the circulation, and the potential benefits of …
as levels of inflammatory cells and proteins) in the circulation, and the potential benefits of …